RANI insider transaction filings
Rani Therapeutics Holdings, Inc. — 30 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen RANI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Gilson Michelle — Director | Grant/award (A): 247,200 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | IMRAN MIR A — Director, 10% owner | Purchase (P): 36,000 @ $0.69 | EDGAR |
| 2026-07-21 | 4 | Javadi Alireza — Chief Technical Officer | Sale (S): 386 @ $0.78 · Tax withholding (F): 309 @ $0.74 | EDGAR |
| 2026-07-21 | 4 | Maestas Nicholas — Chief Financial Officer | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-07-21 | 4 | Imran Talat — Chief Executive Officer, Director | Purchase (P): 35,000 @ $0.72 | EDGAR |
| 2026-07-21 | 4 | Imran Talat — Chief Executive Officer, Director | Sale (S): 8,014 @ $1.41 · Tax withholding (F): 9,076 @ $0.55 · Tax withholding (F): 9,077 @ $0.48 · Tax withholding (F): 7,906 @ $1.40 · Tax withholding (F): 8,916 @ $1.13 · Tax withholding (F): 9,099 @ $0.81 · +1 more | EDGAR |
| 2026-06-05 | 4 | Javadi Alireza — Chief Technical Officer | Grant/award (A): 805,500 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | McKinley Kate — Chief Business Officer | Grant/award (A): 805,500 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Imran Talat — Chief Executive Officer, Director | Grant/award (A): 3,800,000 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Bailey Vasudev Jaiprakash — Director | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Rometty Lisa Ann — Director | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Bassan Abraham — Director | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Ausiello Dennis A — Director | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | BUTEL JEAN LUC — Director | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | IMRAN MIR A — Director, 10% owner | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Bailey Vasudev Jaiprakash — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | Bassan Abraham — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | IMRAN MIR A — Director, 10% owner | Purchase (P): 2,083,334 @ $0.60 · Purchase (P): 2,083,334 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | South Cone Investments Limited Partnership — 10% owner | Sale (S): 1,923,000 @ $2.41 · Sale (S): 4,000,000 @ $2.77 | EDGAR |
| 2025-08-05 | 4 | McKinley Kate — Chief Business Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Rometty Lisa Ann — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Farquharson Andrew — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Nanavaty Maulik — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Ausiello Dennis A — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | BUTEL JEAN LUC — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | IMRAN MIR A — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Hashim Mir — Chief Scientific Officer | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | McKinley Kate — Chief Business Officer | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Imran Talat — Chief Executive Officer, Director | Grant/award (A): 1,053,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Sanford Svai S — Chief Financial Officer | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Rani Therapeutics Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RANI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →